Sanofi SA (NASDAQ:SNY)

46.46
Delayed Data
As of Sep 20
 +1.54 / +3.43%
Today’s Change
40.00
Today|||52-Week Range
46.60
+7.03%
Year-to-Date
Trovagene's Onvansertib Shows Response in Phase Ib AML Study
Sep 20 / Zacks.com - Paid Partner Content
Aimmune's Peanut Allergy Drug Gets FDA Committee's Support
Sep 16 / Zacks.com - Paid Partner Content
CGM Devices Gain Steam, Set New Trend in Diabetes Management
Sep 20 / Zacks.com - Paid Partner Content
Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use
Sep 13 / Zacks.com - Paid Partner Content
Alnylam Focuses on Pipeline Development Amid Competition
Sep 19 / Zacks.com - Paid Partner Content
J&J's Ponesimod Superior to Aubagio in Relapsing MS Patients
Sep 12 / Zacks.com - Paid Partner Content
Alnylam Begins Phase III Study on Onpattro for New Indication
Sep 17 / Zacks.com - Paid Partner Content
Lexicon (LXRX) Settles With Sanofi for $260M, Shares Rally
Sep 11 / Zacks.com - Paid Partner Content
Abbott Partners With Sanofi to Upgrade Diabetes Management
Sep 17 / Zacks.com - Paid Partner Content
Should Value Investors Buy Sanofi (SNY) Stock?
Sep 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close44.92
Today’s open45.53
Day’s range45.43 - 46.60
Volume3,554,565
Average volume (3 months)1,473,693
Market cap$109.1B
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+19.94%
Earnings growth (this year)+4.16%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+2.83%
P/E ratio29.5
Price/Sales2.68
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+1.81+1.58%
AZNAstraZeneca+0.57+1.28%
ABBVAbbVie+0.72+1.00%
GSKGlaxoSmithKline+0.31+0.75%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateOctober 31, 2019
EPS forecast (this quarter)$0.99
Annual revenue (last year)$40.7B
Annual profit (last year)$5.1B
Net profit margin12.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Paul Hudson
Chief Financial Officer &
Executive Vice President
Jean-Baptiste Chasseloup de Chatillon
Corporate headquarters
Paris, Ile-de-france

Forecasts